Compositions for Reducing Hair Loss and/or Increasing Hair Regrowth
The invention relates to a composition comprising 2% to 5% minoxidil, 0.01% to 15% finasteride and 0.01% to 15% of a prostaglandin analogue. In one embodiment, the prostaglandin analogue is latanoprost. In a preferred embodiment, the composition comprises 5% minoxidil, 0.1% finasteride and 0.03% latanoprost. The invention also relates to the use of the said composition to reduce hair loss and/or increase regrowth of hair in a human subject.
1 . A composition comprising 2% to 5% minoxidil, 0.01% to 15% finasteride and 0.01% to 15% of a prostaglandin analogue.
2 . The composition according to claim 1 comprising 5% minoxidil, 0.5% finasteride and 0.1% of a prostaglandin analogue.
3 . The composition according to claim 1 comprising 5% minoxidil, 0.1% finasteride and 0.03% of a prostaglandin analogue.
4 . The composition according to claim 1 , wherein the prostaglandin analogue is latanoprost, travoprost, bimatoprost, tafluprost or unoprostone.
5 . The composition according to claim 4 , wherein the prostaglandin analogue is latanoprost.
6 . A composition comprising 5% minoxidil, 0.1% finasteride and 0.03% latanoprost.
7 . The composition according to claim 1 for use in reducing hair loss; in increasing regrowth of hair; or in reducing hair loss and increasing regrowth of hair in a human subject.
8 . The composition of claim 7 , wherein the human subject is a male.
9 . The composition of claim 7 , wherein the human subject is a female.
10 . The composition according to claim 1 for topical administration.
11 . The composition according to claim 10 which is in the form of a spray.
12 . Use of the composition as defined in claim 1 to reduce hair loss; increase regrowth of hair; or reduce hair loss and increase regrowth of hair in a human subject.
13 . Use of the composition as defined in claim 1 in the manufacture of a medicament to reduce hair loss; increase regrowth of hair; or reduce hair loss and increase regrowth of hair in a human subject.
14 . The use according to claim 12 , wherein the human subject is a male.
15 . The use according to claim 12 , wherein the human subject is a female.
16 . The use according to claim 12 , wherein the composition is for topical administration.
17 . The use according to claim 16 , wherein the composition is in the form of a spray.
18 . The use according to claim 13 , wherein the human subject is a male.
19 . The use according to claim13 wherein the human subject is a female.
20 . The use according to claim 13 , wherein the composition is for topical administration.